Medyssey is committed to generating, developing, and commercializing products that improve the quality of patients'​ lives and provide reproducible clinical outcomes. In the company's quest to become a global market leader, Medyssey designs, develops, manufactures, and markets innovative products for the surgical treatment of spine disorders through novel instrumentation and advanced solutions designed to improve spinal fusion rates and improve clinical outcomes.Medyssey was founded in 2003 by Edward J.W. Jang, and is publicly listed on the KONEX Exchange (Korea New Exchange). With worldwide headquarters in Seoul, Korea, and North American headquarters in Chicago, Medyssey has branch sales offices in China, Mexico, Brazil, and Chile. Medyssey's technological advancement of spinal surgery is rapidly growing in the Asian Pacific, Americas, EU, and emerging international markets, with a significant position in the U.S. market. Our distribution network now spans 30 countries on six continents.